LAL-BR/2001: Study treatment to low risk ALL.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Asparaginase; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Dexamethasone; Etoposide; Hydrocortisone; Mercaptopurine; Methotrexate; Methotrexate; Prednisolone; Prednisolone; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 20 Jan 2016 Biomarkers information updated
- 19 Nov 2013 Planned end date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 19 May 2011 Planned end date changed from 1 Dec 2009 to 1 Dec 2013 as reported by ClinicalTrials.gov.